Drug
Kcp 330
Kcp 330: highest development phase Phase 1, developed by Karyopharm Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Karyopharm Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| KCP-330 NCT01896505 | Phase 1 | Sarcoma |
Latest
No recent events.
Follow Kcp 330 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.